Who has invested in Regulus Therapeutics?

Novartis AG are named among the investors backing Regulus Therapeutics.

Regulus Therapeutics Funding: $1.7B Raised, IPO (2025)

Regulus Therapeutics funding overview

Regulus Therapeutics is based in San Diego County, California. Regulus Therapeutics has raised $1.7B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in May 2025. The round record for Regulus Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Novartis AG.

Regulus Therapeutics at a glance

Total raised: $1.7B
Latest round: IPO
Latest round date: May 2025
Headquarters: San Diego County, California
Notable investors: Novartis AG

Frequently asked about Regulus Therapeutics funding

How much has Regulus Therapeutics raised?: Regulus Therapeutics has raised $1.7B in total disclosed funding across the rounds on record.
Who has invested in Regulus Therapeutics?: Novartis AG are named among the investors backing Regulus Therapeutics.
What was the latest Regulus Therapeutics funding round?: The most recent disclosed round is an IPO, announced in May 2025.
Where is Regulus Therapeutics based?: Regulus Therapeutics is based in San Diego County, California.
When did Regulus Therapeutics last raise?: The last disclosed Regulus Therapeutics round closed in May 2025 at IPO.

Regulus Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego County below to benchmark round size and investor mix.

Regulus Therapeutics Funding: $1.7B Raised, IPO (2025)

Regulus Therapeutics funding overview

Regulus Therapeutics at a glance

Frequently asked about Regulus Therapeutics funding

Companies related to Regulus Therapeutics (30)

Browse related funding lists (3)